These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 20367506)

  • 61. Early diagnosis of trophoblast produced capillary hypertension (pregnancy-induced hypertension).
    Gojnic M; Pervulov M; Petkovic S; Mostic T; Adamsons K; Papic M; Jeremic K
    Clin Exp Obstet Gynecol; 2004; 31(4):287-8. PubMed ID: 15672969
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of gestational hypertension on fetal growth restriction, endocrine and cardiovascular disorders.
    Zhang HG; Yang L; Qiao ZX; Guo W
    Asian J Surg; 2022 Apr; 45(4):1048-1049. PubMed ID: 35183427
    [No Abstract]   [Full Text] [Related]  

  • 63. Searching for new biomarkers for preeclampsia: is there a role for corin?
    Duvekot JJ; Roeters van Lennep JE
    J Womens Health (Larchmt); 2015 Jul; 24(7):546-7. PubMed ID: 26172997
    [No Abstract]   [Full Text] [Related]  

  • 64. Description of a strong relationship among total cell-free DNA levels, LDH values, AST values and platelet count in patients with HELLP syndrome.
    Stiefel P; Miranda ML; Macher H; Beltran-Romero LM; Muñoz-Hernandez R
    Hypertens Res; 2017 Sep; 40(9):843-845. PubMed ID: 28331215
    [No Abstract]   [Full Text] [Related]  

  • 65. Uric acid: is it time to give up routine testing in management of pre-eclampsia?
    Talaulikar VS; Shehata H
    Obstet Med; 2012 Sep; 5(3):119-23. PubMed ID: 27582868
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Can adverse maternal and perinatal outcomes be predicted when blood pressure becomes elevated? Secondary analyses from the CHIPS (Control of Hypertension In Pregnancy Study) randomized controlled trial.
    Magee LA; von Dadelszen P; Singer J; Lee T; Rey E; Ross S; Asztalos E; Murphy KE; Menzies J; Sanchez J; Gafni A; Gruslin A; Helewa M; Hutton E; Lee SK; Logan AG; Ganzevoort W; Welch R; Thornton JG; Moutquin JM
    Acta Obstet Gynecol Scand; 2016 Jul; 95(7):763-76. PubMed ID: 26915709
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Circulating Maternal Total Cell-Free DNA, Cell-Free Fetal DNA and Soluble Endoglin Levels in Preeclampsia: Predictors of Adverse Fetal Outcome? A Cohort Study.
    AbdelHalim RM; Ramadan DI; Zeyada R; Nasr AS; Mandour IA
    Mol Diagn Ther; 2016 Apr; 20(2):135-49. PubMed ID: 26790664
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effectiveness and safety of 1 vs 4 h blood pressure profile with clinical and laboratory assessment for the exclusion of gestational hypertension and pre-eclampsia: a retrospective study in a university affiliated maternity hospital.
    McCarthy EA; Carins TA; Hannigan Y; Bardien N; Shub A; Walker SP
    BMJ Open; 2015 Nov; 5(11):e009492. PubMed ID: 26582404
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hypertension in pregnancy: natural history and treatment options.
    Foo L; Tay J; Lees CC; McEniery CM; Wilkinson IB
    Curr Hypertens Rep; 2015 May; 17(5):36. PubMed ID: 25833457
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Plasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study.
    Chaiworapongsa T; Romero R; Korzeniewski SJ; Cortez JM; Pappas A; Tarca AL; Chaemsaithong P; Dong Z; Yeo L; Hassan SS
    J Matern Fetal Neonatal Med; 2014 Jan; 27(2):132-44. PubMed ID: 23687930
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia.
    Chaiworapongsa T; Romero R; Savasan ZA; Kusanovic JP; Ogge G; Soto E; Dong Z; Tarca A; Gaurav B; Hassan SS
    J Matern Fetal Neonatal Med; 2011 Oct; 24(10):1187-207. PubMed ID: 21827221
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Association of uric acid with progression to preeclampsia and development of adverse conditions in gestational hypertensive pregnancies.
    Wu Y; Xiong X; Fraser WD; Luo ZC
    Am J Hypertens; 2012 Jun; 25(6):711-7. PubMed ID: 22378034
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Predictive value of clinical and laboratory indices at first assessment in women referred with suspected gestational hypertension.
    Anumba DO; Lincoln K; Robson SC
    Hypertens Pregnancy; 2010 Jan; 29(2):163-79. PubMed ID: 20367506
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Plasma uric acid remains a marker of poor outcome in hypertensive pregnancy: a retrospective cohort study.
    Hawkins TL; Roberts JM; Mangos GJ; Davis GK; Roberts LM; Brown MA
    BJOG; 2012 Mar; 119(4):484-92. PubMed ID: 22251368
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prognostic significance of serum uric acid in women with gestational hypertension.
    Bellomo G; Venanzi S; Saronio P; Verdura C; Narducci PL
    Hypertension; 2011 Oct; 58(4):704-8. PubMed ID: 21876075
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Uric Acid Determination in Gestational Hypertension: Is it as Effective a Delineator of Risk as Proteinuria in High-Risk Women?
    Schmella MJ; Clifton RG; Althouse AD; Roberts JM
    Reprod Sci; 2015 Oct; 22(10):1212-9. PubMed ID: 25717062
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.